CD4 and colitis: A variety of genera can reduce the immune checkpoint inhibitor-induced colitis possibly by limiting the inflammation through expansion of CD4+/FoxP3+ T reg cells and/or production of anti-inflammatory cytokines (Dubin et al., 2016).